Advanced genetic panels for precise diagnosis and management of inherited cardiovascular conditions
Genetic diagnostics is becoming a mainstream practice in the field of cardiology and is recommended in guidelines from AHA, HRS-EHRA, ESC, and CCS. It is also proven to be cost-effective compared with regular clinical screening.
Our panels include over 3,000 genes selected based on curated gene reviews, variant databases (HGMD and ClinVar), most recent literature, and customer requests. We offer enhanced clinical utility, maximized diagnostic yield, empowered differential diagnosis as well as analytically validated up-to-date genes across all our panels.
Genetic diagnostics is the most efficient way to subtype hereditary cardiovascular diseases. It forms the basis for selecting the right treatment and making well-informed disease management decisions.
Genetic testing can help clarify or confirm diagnoses in patients with overlapping clinical findings.
In channelopathies, genetic diagnosis helps define lifestyle recommendations and select adequate medications.
Genetic diagnosis is the most effective tool for family-member risk stratification.
For HCM, genetic testing can differentiate classical sarcomere disease from phenocopies like Fabry disease.
We offer comprehensive genetic testing panels for a wide range of cardiovascular conditions, with average results in 10-21 days.
Genetic testing for aortopathies including Marfan syndrome, Loeys-Dietz syndrome, and other connective tissue disorders.
Comprehensive testing for inherited arrhythmia syndromes including Long QT syndrome, Brugada syndrome, and CPVT.
Testing for hypertrophic, dilated, restrictive, and arrhythmogenic cardiomyopathies with genes like MYH7, MYBPC3, and LMNA.
Our most extensive panel covering over 100 genes associated with various cardiovascular conditions.
Focused testing for HCM-associated genes to differentiate sarcomeric disease from phenocopies.
Testing for desmosomal genes associated with arrhythmogenic right ventricular cardiomyopathy.
Targeted testing for LQTS-associated genes including KCNQ1, KCNH2, and SCN5A to identify specific subtypes.
Genetic testing for both isolated and syndromic forms of congenital heart defects.
Testing for familial hypercholesterolemia and other inherited dyslipidemias with high diagnostic yield.
Genetic testing for inherited cardiovascular disorders provides multiple clinical benefits:
Current guidelines recommend genetic testing for many inherited cardiovascular conditions, with pre- and post-test genetic counseling to help patients understand results and implications.
Contact us today to discuss how our comprehensive cardiology genetic testing can benefit your patients.
Contact Our Team